Seoul National University Hospital

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

730

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

16 drugs in development

Phase 33

Phase 24

Phase 11

Preclinical11

By Therapeutic Area

top 4

Oncology

529%

Cardiovascular

212%

Hematology

16%

Psychiatry

16%

R&D Momentum

86/100

Pipeline Velocity

58/100

Trial Completion Rate

91/100

Pipeline Concentration

33/100

Pipeline Freshness

18/100

Strategic Signals

↗Active in Hematology but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Sep 16, 2026

Recruiting

Effectiveness of an Agentic AI-Based Personalized Dietary Management Algorithm in Health Screening Participants: A Randomized Controlled Trial

Sep 12, 2026

Active, not recruiting

Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE (APS-STROKE)

Sep 12, 2026

Recruiting

Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke (SVO70)

Sep 9, 2026

Completed

Shared Decision Making for Choosing renAl Replacement Therapy in Chronic Kidney Disease Patients (SDM-ART Trial)

Earlier

Sep 4, 2026TrialThe Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients With Neuromuscular Disorder

Aug 28, 2026TrialEffect of Individualized Versus Conventional Blood Pressure Management on Major Adverse Cardiac, Cerebrovascular, and Renal Events After Major Non-cardiac Surgery: Multicenter, Randomized Controlled Trial

Aug 27, 2026TrialEffect of a Multimodal Antiemetic Protocol on Postoperative Nausea and Vomiting in Patients Undergoing Flap Surgery for Head and Neck Cancer: A Prospective Randomized Controlled Trial

Aug 26, 2026TrialTransition of Care in Pediatric Rare Endocrine Disorders: Assessing Unmet Needs and Implementing a Standardized Transition Program

2 more events

Aug 26, 2026TrialComparison of Efficacy and Safety Between Eleveld PK/PD Model-based Dosing and Standard Dosing During General Anesthesia

Aug 22, 2026TrialEffectiveness and Safety of PERIoperative Factor Xa Inhibitor Discontinuation in Patients With Atrial Fibrillation Who Undergoing Minor Bleeding Risk Elective Procedure or Surgery: A Prospective, Multicenter, Noninterventional Study (PERIXa Study)

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Therapeutic Area

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Cardiovascular(2 drugs)

—

Cardiovascular(2 drugs)

Hematology(1 drug)

—

Hematology(1 drug)

Oncology(5 drugs)

—

Oncology(5 drugs)

Psychiatry(1 drug)

—

Psychiatry(1 drug)

Unknown / Other(8 drugs)

—

Unknown / Other(8 drugs)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)